Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:European Code Against Cancer, 5th edition : cancer-causing infections and related interventions
Avtorji:ID Alberts, Catharina Johanna (Avtor)
ID Bloem, Paul (Avtor)
ID de Sanjosé, Silvia (Avtor)
ID Graba, Sophie (Avtor)
ID Leja, Marcis (Avtor)
ID Malfertheiner, Peter (Avtor)
ID Matičič, Mojca (Avtor), et al.
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (1,72 MB)
MD5: E32811D332ABD5B58B90186E8AF40CA6
 
URL URL - Izvorni URL, za dostop obiščite https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70172
 
Jezik:Angleški jezik
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:The main infections that cause cancer in the European Union (EU) are Helicobacter pylori (H. pylori), human papillomavirus (HPV), hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Altogether, in 2022, these infections accounted for ~ 5% of all cancers in the EU, mainly of the stomach, cervix uteri and liver. The largest burden of infection-caused cancers was found in the south of the EU and near the eastern border. Substantial progress in the efficacy of interventions against these infections has been made since the release of the 4th edition of the European Code Against Cancer in 2015. Cancers due to infections can increasingly be prevented by prophylactic vaccines (HPV and HBV) and/or prompt diagnosis and treatment that can either cure (HCV and H. pylori) or slow down the infection (HBV and HIV), thus substantially reducing disease risk. Tools to tackle carcinogenic infections are also increasingly accessible and affordable in the EU, but their implementation is slow. Public awareness, political will and cost-effective protocols are necessary to establish large programmes of vaccination or testing and treatment. Progress monitoring, as well as avoiding disinformation and stigma, is crucial to ensure that advances in medical progress are fully leveraged. The recently published 5th edition of the European Code Against Cancer therefore recommends: (1) vaccinate girls and boys against HBV and HPV at the age recommended in your country; (2) take part in testing and treatment for HBV and HCV, HIV and H. pylori, as recommended in your country.
Ključne besede:Helicobacter pylori, HBV, HIV, European Code Against Cancer, cancer, hepatitis B virus, hepatitis C virus, human immunodeficiency virus, human papillomavirus
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2026
Št. strani:str. 96-116
Številčenje:Vol. 20, issue 1
PID:20.500.12556/DiRROS-27242 Novo okno
UDK:616.9
ISSN pri članku:1878-0261
DOI:10.1002/1878-0261.70172 Novo okno
COBISS.SI-ID:266758403 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 30. 1. 2026;
Datum objave v DiRROS:30.01.2026
Število ogledov:207
Število prenosov:96
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Molecular oncology
Založnik:Elsevier
ISSN:1878-0261
COBISS.SI-ID:527178265 Novo okno

Gradivo je financirano iz projekta

Financer:EC - European Commission
Številka projekta:10107524
Naslov:EU4Health programme
Akronim:EU4H

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Nazaj